rs112736576 - UBIAD1 - MTCYBP45
Magnitude 2.2 · 1 study on file
Reported associations
-
Genome-wide association study identifies glutamate ionotropic receptor GRIA4 as a risk gene for comorbid nicotine dependence and major depression - Unknown journal (n.d.) · Unknown authors · PubMed 30287806
ABSTRACT: Smoking and major depression frequently co-occur, at least in part due to shared genetic risk. However, the nature of the shared genetic basis is poorly understood. To detect genetic risk variants for comorbid nicotine dependence (ND) and major depression (MD), we conducted genome-wide association study (GWAS) in two samples of African-American participants (Yale-Penn 1 and 2) using linear mixed model, followed by meta-analysis. 3724 nicotine-exposed subjects were analyzed: 2596 from Yale-Penn-1 and 1128 from Yale-Penn-2. Continuous measures (Fagerström Test for Nicotine Dependence (FTND) scores and DSM-IV MD criteria) rather than disorder status were used to maximize the power of the GWAS. Genotypes were ascertained using the Illumina HumanOmni1-Quad array (Yale-Penn-1 sample)
Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.
Lifestyle context
Concrete actions anchored to the cited research. We do not prescribe, we describe.
Discuss with your doctor
-
Depression and nicotine dependence comorbidity Moderate
rs112736576 shows genetic association with both major depression and nicotine dependence, indicating need for integrated risk assessment.
Screening
-
Mental health and mood symptoms Moderate
rs112736576 associated with major depression severity in GWAS, suggesting increased vulnerability.
Annual mental health screening; more frequent if symptomatic
-
Nicotine dependence and addiction risk Moderate
rs112736576 associated with increased nicotine dependence in GWAS (effect 1.14), suggesting genetic predisposition.
Screen for current or past nicotine use; monitor for addiction symptoms